Inclusion Criteria : includes presence of all the following : 
  -  one or more clinical symptoms ( persistent cough , recurrent hemoptysis , weight loss , malaise , fever and dyspnea ) for â‰¥ 3 months
  -  slowly progressive or persistent radiological findings ( one or more cavities and surrounding fibrosis , infiltrates , consolidation , with or without fungal ball or progressive pleural thickening ) on computed tomography ( CT ) of the thorax
  -  immunological ( A. fumigatus - specific IgG > 27 mgA / L or positive Aspergillus precipitins ) or microbiological evidence of Aspergillus infection ( growth of Aspergillus in respiratory secretions or serum galactomannan index > 0.5 or BALF galactomannan index > 1 ) and , 
  -  exclusion of other pulmonary disorders with similar presentation . 
Exclusion Criteria : 
  -  failure to provide informed consent
  -  patients on immunosuppressive drugs , intake of prednisolone ( or equivalent ) > 10 mg for at least 3 weeks or a diagnosis of human immunodeficiency virus syndrome
  -  intake antifungal azoles for > 3 weeks in the preceding six months
  -  subjects with active pulmonary infection due to mycobacterium tuberculosis or mycobacteria other than tuberculosis ( MOTT ) 
  -  subjects with others forms of pulmonary aspergillosis ( allergic bronchopulmonary aspergillosis , chronic necrotizing aspergillosis and angio - invasive aspergillosis ) 
  -  pregnancy